` 300685 (Amoy Diagnostics Co Ltd) vs Shanghai Composite Comparison - Alpha Spread

300685
vs
Shanghai Composite

Over the past 12 months, has underperformed Shanghai Composite, delivering a return of -2% compared to the Shanghai Composite's 7% growth.

Stocks Performance
300685 vs Shanghai Composite

Loading

Performance Gap
300685 vs Shanghai Composite

Loading
300685
Shanghai Composite
Difference

Performance By Year
300685 vs Shanghai Composite

Loading
300685
Shanghai Composite
Add Stock

Competitors Performance
Amoy Diagnostics Co Ltd vs Peers

Shanghai Composite
300685
ABBV
AMGN
GILD
VRTX
Add Stock

Amoy Diagnostics Co Ltd
Glance View

Market Cap
8.2B CNY
Industry
Biotechnology

Amoy Diagnostics Co., Ltd., nestled in the bustling city of Xiamen, China, has carved out a niche in the world of molecular diagnostics. Founded in 2008, the company has quickly become a pioneer in precision medicine, focusing on the development and commercialization of technologies for the detection of genetic mutations. At the heart of its operation lies its proprietary ADx-ARMS technology, an innovative method allowing for the precise and sensitive detection of mutations in tumor tissues and blood, facilitating oncology diagnostics. This technology not only empowers oncologists with critical insights for tailored cancer treatments but underscores Amoy Diagnostics' commitment to transforming patient care through cutting-edge genetic testing. The commercial prowess of Amoy Diagnostics is, however, much more than its technological innovations. The company thrives on a robust business model that hinges on a symbiotic relationship with the pharmaceutical industry and healthcare providers. By offering diagnostic services and research kits, Amoy Diagnostics provides crucial support in the development of targeted therapies, enabling pharmaceutical companies to test and bring to market personalized medicine solutions. Their revenue stream is bolstered by strategic partnerships and licensing agreements, which allow them to expand their portfolio and market reach both domestically and internationally. This dynamic approach not only ensures a wide adoption of their diagnostic solutions but also firmly positions Amoy Diagnostics as a key player in the rapidly growing field of precision oncology.

Intrinsic Value
27.71 CNY
Undervaluation 26%
Intrinsic Value
Price
Back to Top